Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Take our 2-minute eligibility quiz and we'll let you know on the spot
If your prescription is written for type 2 diabetes: Ozempic, Mounjaro, Victoza, and Rybelsus are covered with prior authorization Prior authorization requires documentation of A1C above 7% (or above 8% for some managed care plans), trial of metformin, and contraindication screening Weight loss is considered a beneficial side effect, not the primary indication Monthly copay: $0 If your prescription is written for chronic weight management: Wegovy, Zepbound, and Saxenda are covered with prior authorization Prior authorization requires BMI criteria, comorbidity documentation (if BMI 27-29.9), step therapy completion, and contraindication screening Diabetes is a qualifying comorbidity, but the prescription must be written for obesity, not diabetes Monthly copay: $0 If your prescription is written off-label (diabetes medication prescribed for weight loss in a patient without diabetes): Denied automatically No appeal pathway unless the provider can document an FDA-approved use that the pharmacy benefit manager's system didn't recognize The diagnosis on the prescription determines the coverage pathway
Reduces oxidative stress Age-related diseases get associated with low glutathione levels
Ellithy MA, Ghali RR, Elghamry WR, et al
Of course, there are also conditions that can rule out such medication
